Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Lachmann

Showing results (41-50 of 287) with videos related to

Pageof 29
Sort By:
Asian Pacific Journal of Allergy and Immunology|June 1, 1990
Antibody engineering: current status and future developmentS Songsivilai, P J Lachmann
Immunology|November 1, 1981
The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cellsP Woo, P J Lachmann
European Journal of Immunology|February 1, 1975
The failure to show a necessary role for C3 in the in vitro antibody responseH Waldmann, P J Lachmann
Clinical and Experimental Immunology|July 1, 1975
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activationP J Lachmann, L Halbwachs
Clinical and Experimental Immunology|September 1, 1971
The quantitation of C6 in rabbit and human seraF Tedesco, P J Lachmann
Clinical and Experimental Immunology|June 1, 1972
The relation of deoxyribonuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB-NZW miceK Hadjiyannaki, P J Lachmann
Clinical Allergy|June 1, 1971
Hereditary angio-oedema: a review with particular reference to pathogenesis and treatmentK Hadjiyannaki, P J Lachmann
Nature|February 2, 1978
Coupling PPD to tumour cells enhances their antigenicity in BCG-primed miceP J Lachmann, K Sikora
Scandinavian Journal of Immunology|January 1, 1976
Factor B of the alternative complement pathway on human lymphocytesL Halbwachs, P J Lachmann
Immunological Reviews|January 7, 1998
Complement and immunity to virusesP J Lachmann, A Davies
Pageof 29

Showing results (41-50 of 287) with videos related to

Sort By:
Pageof 29
Asian Pacific Journal of Allergy and Immunology|June 1, 1990
Antibody engineering: current status and future developmentS Songsivilai, P J Lachmann
Immunology|November 1, 1981
The detection and characterization of a membrane protein with Factor B-like activity on human lymphoid cellsP Woo, P J Lachmann
European Journal of Immunology|February 1, 1975
The failure to show a necessary role for C3 in the in vitro antibody responseH Waldmann, P J Lachmann
Clinical and Experimental Immunology|July 1, 1975
The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activationP J Lachmann, L Halbwachs
Clinical and Experimental Immunology|September 1, 1971
The quantitation of C6 in rabbit and human seraF Tedesco, P J Lachmann
Clinical and Experimental Immunology|June 1, 1972
The relation of deoxyribonuclease inhibitor levels to the occurrence of antinuclear antibodies in NZB-NZW miceK Hadjiyannaki, P J Lachmann
Clinical Allergy|June 1, 1971
Hereditary angio-oedema: a review with particular reference to pathogenesis and treatmentK Hadjiyannaki, P J Lachmann
Nature|February 2, 1978
Coupling PPD to tumour cells enhances their antigenicity in BCG-primed miceP J Lachmann, K Sikora
Scandinavian Journal of Immunology|January 1, 1976
Factor B of the alternative complement pathway on human lymphocytesL Halbwachs, P J Lachmann
Immunological Reviews|January 7, 1998
Complement and immunity to virusesP J Lachmann, A Davies
Pageof 29